RLX's Q1 2023 Financial Report: 89% YoY Revenue Drop

May.17.2023

RLX Tech's Q1 2023 report reveals 89% YoY decrease in revenue and net loss of CNY 56.3 million.

On May 17th, fog core technology (NYSE: RLX) released its first quarter financial report for 2023, ending on March 31st.

According to the financial report, Fogcore Technology's net revenue in the first quarter was CNY 188.9 million (approximately USD 27.5 million), an 89% decrease compared to the same period last year when it was CNY 1.7145 billion. The net loss was CNY 56.3 million (approximately USD 8.2 million) compared to a net profit of CNY 687.1 million in the same period last year.

#North America #United States #Traditional tobacco #financial report #Report

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.

Nov.03

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Israel Proposes E-Cigarette Tax Reform Expected to Raise 154 million USD Shekels Annually

Israel’s Finance Ministry has proposed a 2026 economic reform introducing new taxes and licensing for e-cigarettes. The plan would impose a NIS 1-per-ml tax on vape liquids and NIS 30 per device, abolish VAT exemptions in Eilat, and is expected to generate about NIS 500 million（154 million USD） annually.

Nov.10 by 2FIRSTS.ai

Malaysia’s Home Ministry Urges Study of IQOS Tobacco Device Ahead of Potential Legislation

Malaysia’s Home Ministry has recommended that the National Poison Centre conduct a study on the IQOS heated tobacco device, developed by a leading global tobacco company. Minister Datuk Seri Saifuddin Nasution Ismail said the research would help the government prepare future legislation addressing emerging nicotine technologies. While health risks remain uncertain, officials stress the need for proactive, adaptable legal frameworks.

Nov.27 by 2FIRSTS.ai